Home › Research › Down syndrome and Alzheimer's
[Alzheimer's dementia in people with Down syndrome : Results of guideline-assisted expert interviews on healthcare deficits in the diagnostics and treatment as well as solution approaches]
Hüer T, Weitzel M, Giebel GD, Raszke P, Wasem J, Levin J, Nübling G, Wagemann O et al.. Zeitschrift fur Gerontologie und Geriatrie, 2024-10-09
Topic: Risk, prevention and care in population studies
Plain-language summary
Background People with Down syndrome have a genetically increased risk of developing early onset Alzheimer's dementia. An interview study with healthcare providers, patient representatives and employees in residential and work facilities was conducted to identify deficits in the healthcare process and approaches to overcoming them. Method In this study 14 semi-structured interviews were conducted and analyzed using qualitative content analysis. Results A lack of knowledge and experience on the part of medical service providers in dealing with and providing medical care for people with Down syndrome was identified as a key challenge. In addition, the diagnosis of dementia in people with Down syndrome is difficult for various reasons (including lack of appropriate diagnostic tools in standard care and lack of time or financial resources). Doubts were expressed about the efficacy of antidementia medications and the reasons for the increased use of sedatives were discussed. Attentive observation of behavior and involvement of caregivers, regular review and reduction of polypharmacy and the use of alternative behavior modification techniques were mentioned as possible solutions. Conclusion The identified deficits in the medical care of the target population and the approaches to solving them will be incorporated into the development of health policy recommendations in order to optimize the care situation of those affected in the long term.
What this study adds
Evidence grade: Low
Interviews with providers and caregivers identified major gaps in diagnosing and treating dementia in people with Down syndrome, including lack of knowledge, lack of suitable diagnostic tools, and doubts about the efficacy of antidementia medications. Suggested solutions included closer observation of behavior, caregiver involvement, and reducing polypharmacy, but no treatment was tested.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hüer, T., Weitzel, M., Giebel, G. D., Raszke, P., Wasem, J., Levin, J., et al. (2025). [Alzheimer's dementia in people with Down syndrome : Results of guideline-assisted expert interviews on healthcare deficits in the diagnostics and treatment as well as solution approaches]. Zeitschrift fur Gerontologie und Geriatrie. https://doi.org/10.1007/s00391-024-02371-8
Vancouver
Hüer T, Weitzel M, Giebel GD, Raszke P, Wasem J, Levin J, et al. [Alzheimer's dementia in people with Down syndrome : Results of guideline-assisted expert interviews on healthcare deficits in the diagnostics and treatment as well as solution approaches]. Zeitschrift fur Gerontologie und Geriatrie. 2025. doi:10.1007/s00391-024-02371-8. PMID: 39384617.
BibTeX
@article{huer2025-39384617,
author = {Hüer, T. and Weitzel, M. and Giebel, G. D. and Raszke, P. and Wasem, J. and Levin, J. and Nübling, G. and Wagemann, O. and others},
title = {{[Alzheimer's dementia in people with Down syndrome : Results of guideline-assisted expert interviews on healthcare deficits in the diagnostics and treatment as well as solution approaches]}},
journal = {Zeitschrift fur Gerontologie und Geriatrie},
year = {2025},
doi = {10.1007/s00391-024-02371-8},
pmid = {39384617},
url = {https://doi.org/10.1007/s00391-024-02371-8}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Background People with Down syndrome have a genetically increased risk of developing early onset Alzheimer's dementia.
- Results A lack of knowledge and experience on the part of medical service providers in dealing with and providing medical care for people with Down syndrome was identified as a key challenge.
Why it matters
Interviews with providers and caregivers identified major gaps in diagnosing and treating dementia in people with Down syndrome, including lack of knowledge, lack of suitable diagnostic tools, and doubts about the efficacy of antidementia medications. Suggested solutions included closer observation of behavior, caregiver involvement, and reducing polypharmacy, but no treatment was tested.
Study details
- Evidence strengthLow
How this study scored 35/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Zeitschrift fur Gerontologie und Geriatrie) |
| Journal's citation record | 0 / 4 | Zeitschrift für Gerontologie und Geriatrie: journal h-index 61 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Anke Walendzik: h-index 7 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Ludwig-Maximilians-Universität München: institution h-index 1,224 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39384617) |
| Free to read | 2 / 2 | Free to read |
| Total | 35 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1007/s00391-024-02371-8
- PubMed: 39384617
- Original source →
- Free full text: Zeitschrift für Gerontologie und Geriatrie →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.